IQVIA Holdings Inc

IQV

Company Profile

  • Business description

    Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

  • Contact

    2400 Ellis Road
    DurhamNC27703
    USA

    T: +1 919 998-2000

    E: [email protected]

    https://www.iqvia.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    91,000

Stocks News & Analysis

stocks

Undervalued by 17%, this US cybersecurity leader is a buy for 2026

Here’s a wide-moat company with strong secular tailwinds in a promising industry—and an attractive stock price, too.
stocks

Tough conditions for ASX listed wagering leader

Wagering continues to be challenged in Australia.
stocks

Chart of the Week: Inflation fears dampen sentiment on retailers

Rising inflation is the fly in the ointment.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,059.2014.50-0.16%
CAC 408,243.479.550.12%
DAX 4025,127.465.200.02%
Dow JONES (US)49,266.11270.030.55%
FTSE 10010,044.693.52-0.04%
HKSE26,149.31309.64-1.17%
NASDAQ23,480.02104.26-0.44%
Nikkei 22551,117.26844.72-1.63%
NZX 50 Index13,719.312.450.02%
S&P 5006,921.460.530.01%
S&P/ASX 2008,729.8017.10-0.20%
SSE Composite Index4,082.982.79-0.07%

Market Movers